Ep. 13
Malignant Pleural Mesothelioma: The Signature Cancer of Asbestos
0 min2026-08-21
Why is mesothelioma considered the defining disease of asbestos exposure? And why are people still being diagnosed decades after their last contact with asbestos? In this episode, we explore the biology, epidemiology, diagnosis, and treatment of malignant mesothelioma.
Key takeaways
- Mesothelioma develops primarily in the pleura, peritoneum, and rarely in the pericardium and tunica vaginalis.
- The latency period typically spans three to five decades, making diagnosis particularly challenging.
- WHO and IARC recognize asbestos as the principal cause and conclude that no level of exposure can be considered safe.
- Recent advances in immunotherapy, targeted therapies, and multidisciplinary care are improving survival for selected patients.
More episodes
Continue listening to Asbestos Insight.
Need an asbestos professional?
Browse verified asbestos services by country and city. Direct contact, no commission, no middleman.
Browse the directory